A note on the failure of CGP 19835 A (MTP-PE) to influence the course of influenza A2 infection in human volunteers.
A single dose of the immunomodulator CGP A (MTP-PE) given intranasally to human volunteers 24 h prior to challenge with influenza A2 virus failed to protect against infection or ameriolate any subsequent illness.